Main Subject - Internet and Businesses Online

Really? I mean, we're all concerned with the size of our list, and I'll be you check your stats each and every day to see how many members you gained overnight. But let me tell you something.

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

.. Size doesn't matter, responsiveness does.

So, what's responsivity? It's the rate at which the people on your list buy the product you recommend to them or sign up for whatever your offer

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

may be. For instance, if your list is 10,000 people and 3,000 of them buy something when you send an email to them, my responsivity rate is 30%. That's pretty awesome, right? Well, it is, and

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

you probably won't see rates that high, but I wanted a simple example to show you what I mean.

But if your list isn't buying, don't call them losers. The problem might be you.

Where did you

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

build your list? Was it in your niche market? When you get subscribers from that market, they're very highly targeted, and your response rates will always be better. As an example, if you're

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

in the fishing equipment business, and you don't sell to people who fish, how much stuff do you think you'll sell? Not much.

Another thing about who's on your list is how did you get them?

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

I mean, were they single or double opted-in? Double opted-in list members are usually more responsive. They've taken the time to click the confirmation link, and they're interested in you and

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

what you have to offer them. Single opted-in list members may have trouble remembering who you are and unless your first message goes out to them immediately, which your welcome message shoul

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

d do, anyway, but even when you do, they may unsubscribe or even make a spam complaint. But even though your autoresponder has your back, and single opt-in is definitely faster, the list memb

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

rs you get this way will probably much less responsive.

Next, consider your autoresponder's role in this. What's their deliverabilty rate? How many of your customers even see your email? If

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

you can't get the information at the site, then call or email them and ask. If your service can't or won't tell you, think about hiring another. People on your list can't buy if they don't se

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

e your offer. Right?

Your third consideration is what you use in your "From" line. SuperMarketing, Inc.? Will your list members know that the email is from you? If not, it will either end up

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

in the trash because they'll think it's spam or it will go directly to their junk mail folder with the same end result. Try using your first and last name in the "From" line and see if it w

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

on't boost your response rates.

Number four, does your subject line read: "FREE gift!" or "Open now!" Lines like that will probably get your message directly into the spam bucket. Think abou

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

what you write when you send a message to a friend, and be creative! Boring marketing drivel will just help your list members to ignore your mail.

Fifth is your copy. How good is your messa

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ge? Don't try to sell people in your email. Give them something interesting to wonder about. Curiosity will drive them to your squeeze pa

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

e or your sales letter. Get them wondering, don't sell them in an email.

The deal is that you have to test and track everything that you do--everything. Build a separate list that's doub

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

le opt-in, and see if it doesn't get better results. Work on creating cooler subject lines, and better copy. If you can't write, get someone to write these for you. Just don't try to test eve

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ything at once. You can't do it! You'll have no idea what works and what doesn't. Change one thing at a time and keep changing it until you see the results you want to achieve, and than, move

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

to another area. If you don't work toward making things better, your response rates will continue to be miserable. Change, then test and track and see if your response rates don't get better

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/71548/mainsubjects-Man-My-List-Is-Full-of-Cheap-Losers.html">Man, My List Is Full of Cheap Losers</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/71548/mainsubjects-Man-My-List-Is-Full-of-Cheap-Losers.html]Man, My List Is Full of Cheap Losers[/url]

Running a successful business takes a lot of energy and there are so many areas that as a business owner you need to pay attention too. It's not enough to spend heaps of time, money and resources int...

Developing relationships with your clients is paramount in any successful campaign, and to do this, you need more than a series of advertisements...

Internet marketing is highly techno-functional; unless one is familiar with the changing technological trends, it is difficult to remain competitive in the Internet market.

Tags

Links

Main Subject - Man, My List Is Full of Cheap Losers

Related Articles: